37 results
Page 2 of 2
424B3
936ttln
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
2o4sgg07 t0nrm1740s
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
nk9neb
15 Jun 21
Registration of securities (foreign)
12:00am
20-F
EX-2.7
vef9sjbz2jo501
30 Apr 21
Annual report (foreign)
12:53pm
20-F
65ergnnjqui u9v0
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
mb352yqdl it4vw9
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
e4wlsfqgc1 7lqjj0lk3
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
a9ryf ftwa1
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
8g5 wt4uo3k
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
98ls 5bl9m9qkk7x
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
iv3kh254vk2bjahs86r
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
zkktj 61woahr
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
y1qx5ks4zlll5hi30235
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
98ncwefvgvkdh4hil g6
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
yqbojqi4n ygnxluw
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
3peeb47qd 8b8d2rj
29 May 20
Draft registration statement (amended)
12:00am
DRS
kwpukj9du
19 Feb 20
Draft registration statement
12:00am